Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
I've been with Eastman for a while now and I'm feeling the same unease. The 'optimizing operations' language definitely rings a bell. It feels like a lot of departments are being squeezed, and there's a noticeable slowdown in bringing new initiatives to fruition. The lack of transparency from leadership is creating a lot of speculation, which doesn't help morale. Hoping this is just a temporary phase and not a sign of deeper issues, but it's hard not to worry when the atmosphere shifts this noticeably.
It’s not just R&D, the sentiment seems to be spreading across the company. The 'market uncertainties' excuse feels a bit thin when you see other chemical companies continuing to invest and expand. I’ve heard similar murmurs about reorgs and a general tightening of budgets. It’s frustrating to be in the dark and feel like things are being decided behind closed doors. Management needs to be more upfront about the company's direction, or at least offer some reassurance.